Cargando…
Perspectives on the translation of in-vitro studies to precision medicine in Cystic Fibrosis
Recent strides towards precision medicine in Cystic Fibrosis (CF) have been made possible by patient-derived in-vitro assays with the potential to predict clinical response to small molecule-based therapies. Here, we discuss the status of primary and stem-cell derived tissues used to evaluate the pr...
Autores principales: | Dumas, Marie-Pier, Xia, Sunny, Bear, Christine E., Ratjen, Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577330/ https://www.ncbi.nlm.nih.gov/pubmed/34740114 http://dx.doi.org/10.1016/j.ebiom.2021.103660 |
Ejemplares similares
-
Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis
por: Silva, Iris A. L., et al.
Publicado: (2022) -
The Equitable Implementation of Cystic Fibrosis Personalized Medicines in Canada
por: Shemie, Genevieve, et al.
Publicado: (2021) -
Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic Fibrosis
por: Perrem, Lucy, et al.
Publicado: (2020) -
Translational precision medicine: an industry perspective
por: Hartl, Dominik, et al.
Publicado: (2021) -
Letting It All Out: Neutrophils in Early Cystic Fibrosis Airway Inflammation
por: Perrem, Lucy, et al.
Publicado: (2019)